Effects of the continuous subcutaneous infusion of foslevodopa-foscarbidopa on swallowing in patients with Parkinson’s disease
This study provides preliminary evidence that CSCI-FF may partially improve swallowing function in patients with advanced PD. Further research with larger cohorts is warranted.
Authors
- Akira Morita (ORCID: https://orcid.org/0000-0001-9785-4755)
- Genki Hoshino
- Keisuke Yoshikawa (ORCID: https://orcid.org/0000-0002-6348-6138)
- Yuji Higashimoto (ORCID: https://orcid.org/0000-0002-9210-9083)
- Hiroyuki Namura
- Hanami Sakata
- Tatsuo Hisatomi
- Atsushi Terayama
- Yuta Fukumoto
- Hiroto Nakamura
- Chiharu Isono
- Toru Michiura
- Yoshitaka Nagai (ORCID: https://orcid.org/0000-0003-1037-3129)
- Rino Inada
- Makoto Samukawa (ORCID: https://orcid.org/0000-0003-3464-0754)
- Makito Hirano (ORCID: https://orcid.org/0000-0003-0759-1627)
- Yoshiyuki Mitsui
- Kazunari Yamana
Institutions
- Kindai University Hospital (JP)
- Kindai University (JP)
Publication Details
- Journal
- Clinical Parkinsonism & Related Disorders
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.prdoa.2025.100378
- Primary Topic
- Dysphagia Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00